Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

R.B. Walter; M. Othus; B. Lowenberg; G.J. Ossenkoppele; S.H. Petersdorf; T. Pabst; M.C. Vekemans; F.R. Appelbaum; H.P. Erba; E.H. Estey

doi:10.3324/haematol.2015.130013

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

R.B. Walter, M. Othus, B. Lowenberg, G.J. Ossenkoppele, S.H. Petersdorf, T. Pabst, M.C. Vekemans, F.R. Appelbaum, H.P. Erba, E.H. Estey

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	E409-E411
Journal	Haematologica
Volume	100
Issue number	10
DOIs	https://doi.org/10.3324/haematol.2015.130013
Publication status	Published - 2015

Access to Document

10.3324/haematol.2015.130013

Cite this

Walter, R. B., Othus, M., Lowenberg, B., Ossenkoppele, G. J., Petersdorf, S. H., Pabst, T., Vekemans, M. C., Appelbaum, F. R., Erba, H. P., & Estey, E. H. (2015). Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica, 100(10), E409-E411. https://doi.org/10.3324/haematol.2015.130013

Walter, R.B. ; Othus, M. ; Lowenberg, B. ; Ossenkoppele, G.J. ; Petersdorf, S.H. ; Pabst, T. ; Vekemans, M.C. ; Appelbaum, F.R. ; Erba, H.P. ; Estey, E.H. / Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. In: Haematologica. 2015 ; Vol. 100, No. 10. pp. E409-E411.

@article{0ccb8d8799fd46e7a8ae7ecd00c765fb,

title = "Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG",

author = "R.B. Walter and M. Othus and B. Lowenberg and G.J. Ossenkoppele and S.H. Petersdorf and T. Pabst and M.C. Vekemans and F.R. Appelbaum and H.P. Erba and E.H. Estey",

year = "2015",

doi = "10.3324/haematol.2015.130013",

language = "Undefined/Unknown",

volume = "100",

pages = "E409--E411",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "10",

}

Walter, RB, Othus, M, Lowenberg, B, Ossenkoppele, GJ, Petersdorf, SH, Pabst, T, Vekemans, MC, Appelbaum, FR, Erba, HP & Estey, EH 2015, 'Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG', Haematologica, vol. 100, no. 10, pp. E409-E411. https://doi.org/10.3324/haematol.2015.130013

Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. / Walter, R.B.; Othus, M.; Lowenberg, B.; Ossenkoppele, G.J.; Petersdorf, S.H.; Pabst, T.; Vekemans, M.C.; Appelbaum, F.R.; Erba, H.P.; Estey, E.H.

In: Haematologica, Vol. 100, No. 10, 2015, p. E409-E411.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

AU - Walter, R.B.

AU - Othus, M.

AU - Lowenberg, B.

AU - Ossenkoppele, G.J.

AU - Petersdorf, S.H.

AU - Pabst, T.

AU - Vekemans, M.C.

AU - Appelbaum, F.R.

AU - Erba, H.P.

AU - Estey, E.H.

PY - 2015

Y1 - 2015

U2 - 10.3324/haematol.2015.130013

DO - 10.3324/haematol.2015.130013

M3 - Article

C2 - 26160876

VL - 100

SP - E409-E411

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 10

ER -